Scientists have redesigned a key piece of MRI hardware using metamaterials, allowing existing scanners to produce clearer ...
Pulmonary arterial hypertension (PAH) is a rare, progressive disease of the precapillary pulmonary arteries, characterized by ...
Levacetylleucine (Aqneursa) improved neurologic symptoms and functioning in adults and children with ataxia-telangiectasia in ...
Prime Medicine, Inc. wins arbitration vs. Beam Therapeutics Inc., advancing PM647 for AATD. Read more on PRME and BEAM stocks ...
Warm compresses are frequently recommended indiscriminately, often without consideration of disease phenotype, inflammatory status or realistic thermal limitations. This article examines the ...
Systemic lupus erythematosus (SLE) is a chronic, complex autoimmune disease that can affect multiple organ systems, with ...
Cereno Scientific (Nasdaq First North: CRNO B), an innovative biotech pioneering treatments to enhance and extend life for people with rare cardiovascular and pulmonary diseases, today announced, that ...
More than 700 continuing-education sessions run across 5 days, July 10–14. Here are the ones to circle first, sorted by practice area, plus a handful that are easy to scroll past and worth catching.
The Cystic Fibrosis Foundation organised a multidisciplinary committee to develop this Position Paper to outline current ...
Mesoblast Achieves Target of 300 Treated Patients in Pivotal Phase 3 Trial for Chronic Low Back Pain
Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that it has achieved its target of at least 300 patients treated in ...
Once rapidly fatal, neglected, and orphan diseases without approved therapeutic options, systemic amyloidoses are now highly ...
Recently published Metastatic Castration-resistant Prostate Cancer Market Insights report includes a comprehensive understanding of current treatment practices, metastatic castration-resistant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results